EU regulation does not adequately consider environmental emissions of pharmaceuticals in global manufacturing supply chains

EU regulation pertaining to good manufacturing practices and environmental risk assessment of pharmaceuticals does not adequately consider the environmental emissions of pharmaceuticals in global manufacturing supply chains, a recent study from the University of Eastern Finland concludes. Published by the European Commission in 2020, the Pharmaceutical Strategy for Europe highlights the need to revise the EU’s general pharmaceutical legislation (Directive 2001/83 and Regulation 726/2004) with […]